Next Article in Journal
Detection of miRNAs in urine of prostate cancer patients
Previous Article in Journal
Mean platelet volume and mean platelet volume/platelet count ratio in risk stratification of pulmonary embolism
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 52
Issue 2
10.1016/j.medici.2016.02.006
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction

by
Akif Arslan
1,*,
Mehmet Ozaydin
1,
Fatih Aksoy
1,
Bahriye Arslan
2,
Hasan Aydin Bas Bas
1,
Dogan Erdogan
1,
Ercan Varol
1 and
Abdullah Dogan
1
1
Department of Cardiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey
2
Department of Family Medicine, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey
*
Author to whom correspondence should be addressed.
Medicina 2016, 52(2), 104-109; https://doi.org/10.1016/j.medici.2016.02.006
Submission received: 14 May 2015 / Revised: 19 February 2016 / Accepted: 29 February 2016 / Published: 11 March 2016
Versions Notes

Abstract

Background and aim: Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST-segment elevation myocardial infarction (STEMI). We evaluated the associa- tion between use of previous angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers (renin-angiotensin system [RAS] blockers) and started RAS blockers after MI and development of AF in patients presenting with acute STEMI.
Materials and methods: This retrospective study enrolled 1000 patients with acute STEMI who were admitted to the coronary care unit. Patients were divided into groups according to the use of RAS blockers before MI and development of AF rates was compared. Predictors of AF were determined by multiple logistic regression analysis.
Results: Of the 1000 patients presenting with STEMI, 247 received and 753 did not receive RAS blockers. The incidence of AF was 7.9%. The incidence of AF in patients receiving RAS blockers and did not receiving RAS blockers before MI were similar (5.7% vs. 8.6% respectively, P = 0.13). On the other hand, AF rate was lower in patients in whom RAS blockers were administered during MI as compared to those in whom these agents were not administered (7.2% vs. 28.6%, P < 0.001). Multiple regression analysis results showed that administration of RAS blockers or statins during hospitalization and left atrial diameter were associated with development of AF in patients with acute STEMI.
Conclusions: Previous therapy with RAS blockers does not reduce the incidence of AF in STEMI. Administration of RAS blockers at the hospital may decrease the AF rate in STEMI.
Keywords: Myocardial infarction; Atrial fibrillation; Renin-angiotensin system Myocardial infarction; Atrial fibrillation; Renin-angiotensin system

Share and Cite

MDPI and ACS Style

Arslan, A.; Ozaydin, M.; Aksoy, F.; Arslan, B.; Bas, H.A.B.; Erdogan, D.; Varol, E.; Dogan, A. Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction. Medicina 2016, 52, 104-109. https://doi.org/10.1016/j.medici.2016.02.006

AMA Style

Arslan A, Ozaydin M, Aksoy F, Arslan B, Bas HAB, Erdogan D, Varol E, Dogan A. Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction. Medicina. 2016; 52(2):104-109. https://doi.org/10.1016/j.medici.2016.02.006

Chicago/Turabian Style

Arslan, Akif, Mehmet Ozaydin, Fatih Aksoy, Bahriye Arslan, Hasan Aydin Bas Bas, Dogan Erdogan, Ercan Varol, and Abdullah Dogan. 2016. "Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction" Medicina 52, no. 2: 104-109. https://doi.org/10.1016/j.medici.2016.02.006

APA Style

Arslan, A., Ozaydin, M., Aksoy, F., Arslan, B., Bas, H. A. B., Erdogan, D., Varol, E., & Dogan, A. (2016). Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction. Medicina, 52(2), 104-109. https://doi.org/10.1016/j.medici.2016.02.006

Article Metrics

Back to TopTop